In simple terms: a mutation is a stable change in genetic sequence that can be copied when cells or viruses replicate. Most mutations have no detectable effect, some contribute to disease, and a small ...

BEAM-301 Achieves Clinical Proof of Concept for Genetic Correction of R83C Mutation in GSDIaInitial Phase 1/2 Data Show Restoration of Endogenous ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the CRISPR/Cas system, colloquially known as gene scissors. These can cut and ...

One genetic mutation may transform the way we treat rheumatoid arthritis, a disease that will affect an estimated one percent of the world. York University researchers have identified a mutation in ...

Scientists have developed an advanced computational tool that helps identify previously invisible genetic mutations in proteins. The tool will help scientists understand how changes in our DNA affect ...

Scientists at UCLA and the University of Toronto have developed an advanced computational tool, called moPepGen, that helps identify previously invisible genetic mutations in proteins, unlocking new ...

A Chinese family case report reveals the rare co-inheritance of β-thalassemia and hereditary elliptocytosis, traced to EPB41 ...

A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...

Integrating new AI screening tools for BRCA and HRD breast-cancer mutations into routine care could lead to earlier detection, more precise treatment, and lives saved. If they are aware of the threat, ...

Precision medicine, targeted and oral therapies, multidisciplinary care, and robust rare disease research are reshaping US cystic fibrosis treatmentDublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "United ...

Ocugen is advancing OCU400 in the Phase 3 liMeliGhT clinical trial, with topline data expected in the first quarter of 2027. The company plans to pursue regulatory submissions following the data ...